Loading
Latest filing published 01 Jun 2009 for AVALON PHARMACEUTICALS INC.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Kenneth C. Carter is a declared insider of Avalon Pharmaceuticals Inc, with filings sourced from SEC (Form 4). The record holds 22 filings, for trades running from 22 August 2006 to 28 May 2009.
On the open market, the record shows 13 purchases worth €21k and 7 sales worth €6,049. Netting one side against the other leaves €15k of net buying. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
A typical purchase (the median) is worth €1,071.
The record was last updated on 1 June 2009 with a transaction in Avalon Pharmaceuticals Inc. The last insider purchase was made public on 23 January 2008, 6,848 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22 of 22 declarations